SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001372514-23-000126
Filing Date
2023-09-01
Accepted
2023-09-01 07:00:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A kiora-definitiveproxyaddit.htm DEFA14A 21117
2 EX-99.1 ex991-pressreleasespecialpa.htm EX-99.1 10632
  Complete submission text file 0001372514-23-000126.txt   32853
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36672 | Film No.: 231230580
SIC: 2834 Pharmaceutical Preparations